Questionable Practice
GSK Ordered to pull misleading adverts
The US government has ordered a drug giant to quit running a series of radio and newspaper ads that call the allergy spray Flonase a cost-effective alternative to pricey allergy pills. ...Read more
----
16th Dec 2003
Questionable Practice
Glaxo's CEO to scoop 5.7 mln stg a year
Jean-Pierre Garnier, chief executive of GlaxoSmithKline Plc , will earn up to 5.7 million pounds ($9.96 million) a year under a new pay package agreed by the pharmaceuticals group, the Sunday Telegraph reported. ... Read more
----
11th May 2004
Fraud Investigation
GlaxoSmithKline faces antitrust investigation
A drug manufacturer being investigated for possible antitrust violations because it cut off shipments to Canadian mail-order pharmacies has to turn its records over to the Minnesota attorney general's office, a judge has ruled. ...Read more
----
19th May 2004
New York sues GlaxoSmithKline
The city of New York has sued drug maker GlaxoSmithKline, claiming that the company engaged in "anticompetitive, fraudulent, and inequitable conduct," when it acquired patents for its anti-depressant Paxil. ... Read more
----
6th Sep 2004
GSK faces anti-depressant lawsuit
GlaxoSmithKline (GSK) is facing a US lawsuit alleging that it covered up negative research findings on its anti-depressant drug Paxil. ... Read more
----
22nd Sep 2004
Questionable Practice
Glaxo drops appeal in Aids drug pricing case
A landmark legal complaint against British drug maker GlaxoSmithKline (GSK) over its Aids drug pricing and policies in South Africa will proceed after GSK dropped its public and repeated vows to appeal a decision allowing the case to go forward, according to AidsHealthcare Foundation (AHF). ... Read more
----
18th Mar 2005
Glaxo shares dip on factory probe
GlaxoSmithKline shares have fallen almost 2% amid fears a US inquiry into manufacturing quality could be widened and may possibly lead to a big fine. On 4 March the US Food and Drug Administration (FDA) seized batches of two drugs from the Puerto Rico plant. ... Read more
----
29th Mar 2006
Questionable Practice
Glaxo agrees US Paxil settlement
GlaxoSmithKline (GSK) has agreed to pay $14m (£8m) to settle US claims that it fraudulently tried to delay competitors to anti-depressant drug Paxil. ... Read more
----
10th Aug 2006
Glaxo pays $70m to end price row
GlaxoSmithKline has agreed to pay out $70m (£36.9m) to settle numerous civil claims of price-fixing in the US. ... Read more
----
29th Jan 2007
Questionable Practice
GSK hid paxil suicide link
Secret emails reveal that the UK's biggest drug company distorted trial results of an anti-depressant, covering up a link with suicide in teenagers. ... Read more
improve the quality of human life by enabling people to do more, feel better and live longer.
No comments: